Follow
Hussein Al Ali
Hussein Al Ali
Anglia Ruskin University
Verified email at aru.ac.uk
Title
Cited by
Cited by
Year
Enhanced γ‐H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry
CN Parris, S Adam Zahir, H Al‐Ali, EC Bourton, C Plowman, PN Plowman
Cytometry Part A 87 (8), 717-723, 2015
362015
The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/-lymphoblastoid cells
EC Bourton, PA Ahorner, PN Plowman, SA Zahir, H Al-Ali, CN Parris
Journal of Cancer 8 (19), 4048, 2017
262017
Efficacy of MDX-124, a novel anti-annexin-A1 antibody, in preclinical models of pancreatic cancer
FC Dempsey, H Al-Ali, SJ Crichton, C Fabian, E Roberts, C Pepper, ...
Journal of Clinical Oncology 40 (4_suppl), 590-590, 2022
12022
MDX-124, a novel annexin-A1 antibody, induces an anti-tumor immune response and wide-ranging anti-cancer activity in multiple preclinical models
FC Dempsey, H Al-Ali, SJ Crichton, C Pepper, CN Parris
Cancer Res 81 (13 Supplement), 1874, 2021
12021
Annexin-A1 as a potential therapeutic target for solid tumors
FC Dempsey, HC Hays, SJ Crichton, H Al-Ali, CN Parris
Cancer Research 80 (16_Supplement), 3356-3356, 2020
12020
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo
HN Al-Ali, SJ Crichton, C Fabian, C Pepper, DR Butcher, FC Dempsey, ...
Oncogene, 1-7, 2024
2024
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo.
C Parris, S Crichton, C Fabian, C Pepper, H Al-Ali, D Butcher, F Dempsey
2023
MDX-124, a novel annexin-A1 antibody, induces significant anti-cancer activity in multiple preclinical models
FC Dempsey, H Al-Ali, SJ Crichton, C Fabian, C Pepper, BZ Qian, XF Li, ...
Cancer Research 82 (12_Supplement), 5294-5294, 2022
2022
Inhibition of MUS81 By siRNA Reverses Resistance to Cisplatin in Human Ovarian Cancer Cell Lines
EC Bourton, S Adam-Zahir, PN Plowman, HN Al-Ali, HA Foster, CN Parris
2021
MDX-124, a novel annexin-A1 antibody, shows anti-tumor efficacy in several preclinical models of triple-negative breast cancer
FC Dempsey, H Al-Ali, SJ Crichton, C Fabian, C Pepper, CN Parris
Presented at the San Antonio Breast Cancer Symposium-December 7, 10, 2021
2021
The identification of circulating tumour cells in prostate cancer using imaging flow cytometry
H Al-Ali
Brunel University London, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–11